Provided by Tiger Trade Technology Pte. Ltd.

RxSIGHT, INC.

4.90
+0.13002.73%
Post-market: 4.86-0.0400-0.82%17:55 EDT
Volume:705.66K
Turnover:3.44M
Market Cap:202.84M
PE:-4.30
High:4.99
Open:4.80
Low:4.67
Close:4.77
52wk High:13.22
52wk Low:4.48
Shares:41.40M
Float Shares:33.77M
Volume Ratio:0.74
T/O Rate:2.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1385
EPS(LYR):-0.9533
ROE:-17.35%
ROA:-10.41%
PB:0.77
PE(LYR):-5.14

Loading ...

RxSight's Utilization-Growth Upside Faces Structural, Competitive Headwinds, BofA Says

MT Newswires Live
·
Sep 23

RxSight is Maintained at Hold by Jefferies

Dow Jones
·
Sep 22

BofA Adjusts Price Target on RxSight to $5.50 From $6.50

MT Newswires Live
·
Sep 22

RxSight price target lowered to $5.50 from $6.50 at BofA

TIPRANKS
·
Sep 22

Rxsight : Bofa Global Research Cuts Price Objective to $5.50 from $6.50

THOMSON REUTERS
·
Sep 22

RxSight Management to Present at Wells Fargo Healthcare Conference

Reuters
·
Aug 27

RxSight’s Long-Term Lens Study: What Ongoing Results Could Mean For RXST Investors

TIPRANKS
·
Aug 13

Eye Care Company Alcon Raises Margin Outlook, Shares Jump

Reuters
·
Aug 11

Alcon Shares Seen Rising After Outlook Hike

Reuters
·
Aug 11

Rxsight’s Earnings Call: Alcon Deal vs. Headwinds

TIPRANKS
·
Aug 09

Analysts Are Neutral on Top Healthcare Stocks: Annexon Biosciences (ANNX), RxSight (RXST)

TIPRANKS
·
Aug 08

J.P. Morgan Sticks to Their Sell Rating for RxSight (RXST)

TIPRANKS
·
Aug 07

RxSight is Maintained at Neutral by UBS

Dow Jones
·
Aug 07

Tarsus Pharmaceuticals Q2 Sales Beat Estimates, Lifts 2026 Xdemvy Sales Outlook

Reuters
·
Aug 06

Germany's Carl Zeiss Meditec 9-Month Revenue Falls 2.9%

Reuters
·
Aug 06

RxSight, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

RxSight Q2 2026 Earnings: Alcon Revenue Offsets a 19% Product Sales Decline

TradingKey
·
Aug 06

RxSight Q2 FY26 Net Loss Widens 2.6% to $12.1 Million; Revenue Rises 0.3% to $33.7 Million

Reuters
·
Aug 06

RxSight Q2 Adjusted Loss Beats Estimates; Withdraws 2026 Guidance

Reuters
·
Aug 06

Rxsight Inc Q2 Operating Expenses USD 39.7 Million

Reuters
·
Aug 06